As the global economy mends, the 2021 growth of CRM197 Protein will have significant change from previous year. According to our (LP Information) latest study, the global CRM197 Protein market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global CRM197 Protein market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States CRM197 Protein market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global CRM197 Protein market, reaching US$ million by the year 2028. As for the Europe CRM197 Protein landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main CRM197 Protein players cover Ligand Pharmaceuticals, Fina Biosolutions, Scarab Genomics, and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of CRM197 Protein market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Research Use
Commercial Use
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Fungal Disease
Viral Disease
Alzheimer's Disease
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Ligand Pharmaceuticals
Fina Biosolutions
Scarab Genomics